FMI: Family Motivational Intervention in Schizophrenia

Sponsor
Academisch Medisch Centrum - Universiteit van Amsterdam (AMC-UvA) (Other)
Overall Status
Unknown status
CT.gov ID
NCT01167556
Collaborator
(none)
147
1
2
59.1
2.5

Study Details

Study Description

Brief Summary

Cannabis use by people with schizophrenia is associated with family distress and poor clinical outcomes. Therefore, an Family Motivational Intervention (FMI) was developed to help parents to motivate their child with a diagnoses of recent-onset schizophrenia to reduce cannabis use.

In a single-blind randomised clinical trail with 75 patients with the diagnosis of schizophrenia, parents will be assigned to either FMI or to routine care. Assessments will be conducted at baseline and at a 10- and 22-month follow-up. The study hypothesis is that FMI will be more effective than routine care in reducing (a) cannabis use in patients and (b) distress and sense of burden in parents.

Condition or Disease Intervention/Treatment Phase
  • Behavioral: Family Motivational Intervention
N/A

Study Design

Study Type:
Interventional
Actual Enrollment :
147 participants
Allocation:
Randomized
Intervention Model:
Parallel Assignment
Masking:
Single (Investigator)
Primary Purpose:
Treatment
Official Title:
Motivational Interviewing and Interaction Skills Training for Carers to Change Cannabis Use in Young Adults With Recent-onset Schizophrenia: Randomised Controlled Trial
Study Start Date :
Mar 1, 2006
Anticipated Primary Completion Date :
Aug 1, 2010
Anticipated Study Completion Date :
Feb 1, 2011

Arms and Interventions

Arm Intervention/Treatment
Experimental: Family Motivational Intervention

An intervention provided to parents consisting of 6 sessions of training in Interactions Skills and 6 sessions training in Motivational Interviewing.

Behavioral: Family Motivational Intervention
A intervention with provided parents 6 sessions of Interaction Skills training and 6 sessions Motivational Interviewing training.

Active Comparator: Routine care for parents

Routine care for parents consisting of 2 sessions psycho-education and individual support

Behavioral: Family Motivational Intervention
A intervention with provided parents 6 sessions of Interaction Skills training and 6 sessions Motivational Interviewing training.

Outcome Measures

Primary Outcome Measures

  1. Cannabis use in patients with a diagnosis of recent-onset schizophrenia [Baseline (before the start of the intervention)]

  2. Cannabis use in patients with a diagnosis of recent-onset schizophrenia [10-month follow-up (3 months after the intervention has ended)]

  3. Cannabis use in patients with a diagnosis of recent-onset schizophrenia [22-month follow-up (15 months after the intervention has ended)]

Secondary Outcome Measures

  1. Medication adherence in patients with a diagnosis of recent-onset schizophrenia [Baseline (before the start of the intervention)]

  2. Medication adherence in patients with a diagnosis of recent-onset schizophrenia [10-month follow-up (3 months after the intervention has ended)]

  3. Medication adherence in patients with a diagnosis of recent-onset schizophrenia [22-month follow-up (15 months after the intervention has ended)]

  4. Quality of life in patients with recent-onset schizophrenia [Baseline (before the start of the intervention)]

  5. Quality of life in patients with recent-onset schizophrenia [10-month follow-up (3 months after the intervention has ended)]

  6. Quality of life in patients with recent-onset schizophrenia [22-month follow-up (15 months after the intervention has ended)]

  7. Stress in parents due to caring for a child with recent-onset schizophrenia [Baseline (before the start of the intervention)]

  8. Stress in parents due to caring for a child with recent-onset schizophrenia [10-month follow-up (3 months after the intervention has ended)]

  9. Stress in parents due to caring for a child with recent-onset schizophrenia [22-month follow-up (15 months after the intervention has ended)]

  10. Expressed emotion in parents of patients with recent-onset schizophrenia [Baseline (before the start of the intervention)]

  11. Expressed emotion in parents of patients with recent-onset schizophrenia [10-month follow-up (3 months after the intervention has ended)]

  12. Expressed emotion in parents of patients with recent-onset schizophrenia [22-month follow-up (15 months after the intervention has ended)]

Eligibility Criteria

Criteria

Ages Eligible for Study:
16 Years to 40 Years
Sexes Eligible for Study:
All
Accepts Healthy Volunteers:
No
Inclusion Criteria:
  • Clinical diagnosis of schizophrenia or psychotic-related disorder

  • Onset of schizophrenia or related disorder within pervious the 10 years

  • Cannabis use at least 2 days per week in the 3 months prior to the assessment

  • Antipsychotic medication in prescribed or indicated

  • At least 10 hours of contact with the parents each week in the last month

Exclusion Criteria:

Contacts and Locations

Locations

Site City State Country Postal Code
1 Academic Medical Center Amsterdam North Holland Netherlands 1066 DP

Sponsors and Collaborators

  • Academisch Medisch Centrum - Universiteit van Amsterdam (AMC-UvA)

Investigators

  • Study Director: Gerard Schippers, Prof. dr., Academisch Medisch Centrum - Universiteit van Amsterdam (AMC-UvA)
  • Principal Investigator: Don Linszen, Prof.dr., Academisch Medisch Centrum - Universiteit van Amsterdam (AMC-UvA)
  • Study Chair: Lieuwe de Haan, Dr., Academisch Medisch Centrum - Universiteit van Amsterdam (AMC-UvA)

Study Documents (Full-Text)

None provided.

More Information

Publications

Responsible Party:
, ,
ClinicalTrials.gov Identifier:
NCT01167556
Other Study ID Numbers:
  • Grant 100003014
First Posted:
Jul 22, 2010
Last Update Posted:
Jul 22, 2010
Last Verified:
Feb 1, 2008

Study Results

No Results Posted as of Jul 22, 2010